OBJECTIVES: Increasing evidence confirms that microbubble (MB)-augmented ultrasound (US) thrombolysis enhances clot lysis with or without tissue plasminogen activator (tPA). Intracranial hemorrhage (ICH) is a major complication militating against tPA use in acute ischemic stroke. We quantified the incidence of ICH associated with tPA thrombolysis and MB + US therapy and compared infarct volumes in a rabbit model of acute ischemic stroke. MATERIALS AND METHODS: Rabbits (n = 158) received a 1.0-mm clot, angiographically injected into the internal carotid artery causing infarcts. Rabbits were randomized to 6 test groups including (1) control (n = 50), embolized without therapy, (2) US (n = 18), (3) tPA only (n = 27), (4) tPA + US (n = 22), (5) MB + US (n = 27), and (6) tPA + MB + US (n = 14). US groups received pulsed wave US (1 MHz, 0.8 W/cm) for 1 hour; rabbits with tPA received intravenous tPA (0.9 mg/kg) over 1 hour. Rabbits with MB received intravenous MB (0.16 mg/kg) given over 30 minutes. Rabbits were killed 24 hours later and infarct volume and incidence, location, and severity of ICH were determined by histology and pathologic examination. RESULTS: Percentage of rabbits having ICH outside the infarct area was significantly decreased (P = 0.004) for MB + US (19%) rabbits compared with tPA + US (73%), US only (56%), tPA (48%), tPA + MB + US (36%), and control (36%) rabbits. Incidence and severity of ICH within the infarct did not differ (P > 0.39). Infarct volume was significantly greater (P = 0.002) for rabbits receiving US (0.97% ± 0.17%) than for MB + US (0.20% ± 0.14%), tPA + US (0.15% ± 0.16%), tPA (0.14% ± 0.14%), and tPA + MB + US (0.10% ± 20%) rabbits; these treatments collectively, excluding US only, differed (P = 0.03) from control (0.45% ± 0.10%). CONCLUSIONS: Treatment with MB + US after embolization decreased the incidence of ICH and efficacy was similar to tPA in reducing infarct volume.
OBJECTIVES: Increasing evidence confirms that microbubble (MB)-augmented ultrasound (US) thrombolysis enhances clot lysis with or without tissue plasminogen activator (tPA). Intracranial hemorrhage (ICH) is a major complication militating against tPA use in acute ischemic stroke. We quantified the incidence of ICH associated with tPA thrombolysis and MB + US therapy and compared infarct volumes in a rabbit model of acute ischemic stroke. MATERIALS AND METHODS:Rabbits (n = 158) received a 1.0-mm clot, angiographically injected into the internal carotid artery causing infarcts. Rabbits were randomized to 6 test groups including (1) control (n = 50), embolized without therapy, (2) US (n = 18), (3) tPA only (n = 27), (4) tPA + US (n = 22), (5) MB + US (n = 27), and (6) tPA + MB + US (n = 14). US groups received pulsed wave US (1 MHz, 0.8 W/cm) for 1 hour; rabbits with tPA received intravenous tPA (0.9 mg/kg) over 1 hour. Rabbits with MB received intravenous MB (0.16 mg/kg) given over 30 minutes. Rabbits were killed 24 hours later and infarct volume and incidence, location, and severity of ICH were determined by histology and pathologic examination. RESULTS: Percentage of rabbits having ICH outside the infarct area was significantly decreased (P = 0.004) for MB + US (19%) rabbits compared with tPA + US (73%), US only (56%), tPA (48%), tPA + MB + US (36%), and control (36%) rabbits. Incidence and severity of ICH within the infarct did not differ (P > 0.39). Infarct volume was significantly greater (P = 0.002) for rabbits receiving US (0.97% ± 0.17%) than for MB + US (0.20% ± 0.14%), tPA + US (0.15% ± 0.16%), tPA (0.14% ± 0.14%), and tPA + MB + US (0.10% ± 20%) rabbits; these treatments collectively, excluding US only, differed (P = 0.03) from control (0.45% ± 0.10%). CONCLUSIONS: Treatment with MB + US after embolization decreased the incidence of ICH and efficacy was similar to tPA in reducing infarct volume.
Authors: Carlos A Molina; Marc Ribo; Marta Rubiera; Joan Montaner; Esteban Santamarina; Raquel Delgado-Mederos; Juan F Arenillas; Rafael Huertas; Francisco Purroy; Pilar Delgado; José Alvarez-Sabín Journal: Stroke Date: 2005-12-22 Impact factor: 7.914
Authors: Andrei V Alexandrov; Robert Mikulik; Marc Ribo; Vijay K Sharma; Annabelle Y Lao; Georgios Tsivgoulis; Rebecca M Sugg; Andrew Barreto; Paul Sierzenski; Marc D Malkoff; James C Grotta Journal: Stroke Date: 2008-03-20 Impact factor: 7.914
Authors: L Dinia; M Rubiera; M Ribo; O Maisterra; G Ortega; M del Sette; J Alvarez-Sabin; C A Molina Journal: Neurology Date: 2009-09-08 Impact factor: 9.910
Authors: Michael Daffertshofer; Achim Gass; Peter Ringleb; Matthias Sitzer; Ulrich Sliwka; Thomas Els; Oliver Sedlaczek; Walter J Koroshetz; Michael G Hennerici Journal: Stroke Date: 2005-06-09 Impact factor: 7.914
Authors: William C Culp; Sean D Woods; Robert D Skinner; Aliza T Brown; John D Lowery; Jennifer L H Johnson; Evan C Unger; Leah J Hennings; Michael J Borrelli; Paula K Roberson Journal: J Vasc Interv Radiol Date: 2011-11-12 Impact factor: 3.464
Authors: William C Culp; Sean D Woods; Aliza T Brown; John D Lowery; Leah J Hennings; Robert D Skinner; Michael J Borrelli; Paula K Roberson Journal: J Neurosci Methods Date: 2012-11-08 Impact factor: 2.390
Authors: M Christine Arthur; Aliza Brown; Kristen Carlson; John Lowery; Robert D Skinner; William C Culp Journal: Mol Neurobiol Date: 2016-08-08 Impact factor: 5.590
Authors: Alison Burgess; Yuexi Huang; Adam C Waspe; Milan Ganguly; David E Goertz; Kullervo Hynynen Journal: PLoS One Date: 2012-08-01 Impact factor: 3.240
Authors: Feng Xie; Shunji Gao; Juefei Wu; John Lof; Stanley Radio; Francois Vignon; William Shi; Jeffry Powers; Evan Unger; E Carr Everbach; Jinjin Liu; Thomas R Porter Journal: PLoS One Date: 2013-07-29 Impact factor: 3.240
Authors: Aliza Brown; Sean Woods; Robert Skinner; Jeff Hatton; John Lowery; Paula Roberson; Leah Hennings; William C Culp Journal: Open Neurol J Date: 2013-10-31